间质瘤
医学
间质细胞
癌症研究
肿瘤细胞
内科学
肿瘤科
病理
主旨
肿瘤微环境
免疫组织化学
边疆
靶向治疗
放射治疗
作者
Sihan Wu,Hao Liu,Yuhan Yin,Jiehan Li,Zhen Zhang,Wei Li,Yang Fu
出处
期刊:Neoplasia
[Elsevier BV]
日期:2026-04-08
卷期号:76: 101306-101306
标识
DOI:10.1016/j.neo.2026.101306
摘要
Gastrointestinal stromal tumors (GISTs), the most common mesenchymal neoplasms of the digestive tract, are primarily driven by mutations in KIT/PDGFRA. The remarkable success of tyrosine kinase inhibitors such as imatinib (IM) in treating GIST has established them as a paradigm of precision medicine in modern oncology. However, acquired resistance to IM remains a major cause of poor prognosis in GIST patients. Exploring novel mechanisms of IM resistance is critically important for improving outcomes. Tumor dormancy and cancer stem cell (CSC) models, observed across multiple malignancies, are closely linked to therapy resistance, tumor recurrence, and metastasis. Emerging evidence suggests that analogous non-genetic persistence states also exist in GIST, including dormant cells and KIT low stem-like/CSC-like subpopulations. This review summarizes the fundamental regulatory mechanisms of tumor dormancy and CSC biology, discusses their candidate manifestations in GIST, and proposes innovative therapeutic strategies based on these insights.
科研通智能强力驱动
Strongly Powered by AbleSci AI